Recent articles

One of Breakthrough T1D’s top legislative priorities has been achieved with the enactment of a three-year renewal of the Special Diabetes Program (SDP). The program, now funded until September 30, 2023 at $150 million per year, will enable researchers to build upon the momentum in type 1 diabetes (T1D) to date and explore new opportunities […]

The Food and Drug Administration (FDA) approved the Medtronic MiniMed 770G artificial pancreas system for use by children aged 2 to 6 with type 1 diabetes (T1D). It is the first marketed device that can automatically adjust insulin delivery based on continuous glucose monitoring (CGM) values for children aged 2-6 years.

The Federal Government has continued its commitment to support diabetes research by providing more than $75 million into the Special Diabetes Program (SDP), which drives forward critical research aimed at curing type 1 diabetes (T1D) and improving the lives of those living with the disease today. The funding, approved by both the House and Senate and signed by the […]

What would intimidate even the most seasoned speakers had little impact on the three teens who met with the Food and Drug Administration (FDA) on behalf of Breakthrough T1D and the type one diabetes (T1D) community. The teens have already been through so much. Sharing their stories of living with T1D, they said, is easy […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.